Globally, 185 million people are living with hepatitis C virus (HCV). There are 300,000 people living with HCV in Canada and 3.5 million people living with HCV in the United States. The vast majority of adults infected with HCV in North America, as well as some other developed countries, are part of the generational cohort composed of individuals born between 1945 and 1964 (called “the baby boomers”). Previous studies implicated both use of infected blood products (prior to the screening of the blood supply) and injection drug use as major contributors to the epidemic in this demographic group.